Opdivo New Drugs For Melanoma Treatment Approved by FDA
The U.S. Food and Drug Administration, FDA, today granted accelerated approval to Opdivo (nivolumab), a new treatment for patients with unresectable (cannot be removed by surgery) or metastatic (advanced) melanoma who no longer respond to other drugs. Melanoma is the…
12/23/2014
